We conclude that depletion of Ajuba in IMR90 leads to a qualitatively similar response to our tumor cell system HTC75, which corresponds to ATR activation, but with a different outcome regarding the nature of the cell cycle profile (G2/M delay in IMR90 versus S-phase delay in HTC75). The gene discussed is ATR; the disease is neoplasm.